Long-Term Assets: The sum of all assets classified as non-current.
Coherus Oncology, Inc. (CHRS) had Long-Term Assets of $51.64M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$12.75M |
|
$-37.64M |
|
$4.04M |
|
$8.70M |
|
$58.63M |
|
$-45.88M |
|
$-0.47M |
|
$-46.35M |
|
$-46.35M |
|
$-46.35M |
|
$-46.35M |
|
$-37.64M |
|
$-46.35M |
|
$-45.88M |
|
$-44.98M |
|
117.14M |
|
117.14M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$206.71M |
|
$1.34M |
|
|
Long-Term Assets |
$51.64M |
$258.34M |
|
$140.39M |
|
$37.05M |
|
$56.94M |
|
$197.33M |
|
$61.01M |
|
$14.78M |
|
$61.01M |
|
121.16M |
|
| Cash Flow Statement Financials | |
$-138.51M |
|
$375.09M |
|
$-273.70M |
|
$126.25M |
|
$89.12M |
|
$-37.13M |
|
$16.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.47 |
|
-- |
|
-- |
|
0.38 |
|
0.61 |
|
68.27% |
|
-359.90% |
|
-359.90% |
|
-- |
|
-363.56% |
|
-295.29% |
|
$-138.51M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
1.28 |
|
0.69 |
|
130.03 |
|
-75.96% |
|
-313.69% |
|
-17.94% |
|
-47.26% |
|
$0.50 |
|
$-1.18 |
|
$-1.18 |
|